Delineation of Target Volume of Stereotactic Radiotherapy for Spinal Tumors
ConditionSpinal Tumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-90
SponsorPeking University Third Hospital
About this trial
The purpose of this study was to compare efficacy and side effects of two target delineation methods for stereotactic radiotherapy of metastatic spinal tumors.
Eligibility criteria
Qualifiers
Patients with spinal metastases or primary tumors receiving stereotactic radiotherapy;
Patients with sufficent pre-treatment imaging data
Patients who can cooperate with imaging review and follow-up after radiotherapy.
Disqualifiers
Patients with an expected survival of less than 3 months;
Patients with second-course radiotherapy;
Patients with physical conditions that cannot tolerate stereotactic radiotherapy;
Patients with extensive spinal metastasis and no local therapeutic value
Trial design
Treatments tested in this trial
- Target volume delineation
Treatment groups
500 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov